Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 93 matching records.
93 results — page 1 of 4
- Level BClinical TrialPubMed
Mesenchymal stem cell-derived exosomes in myocardial infarction repair: therapeutic potential and scaffold-based delivery strategies.
Clinical Trial on Cardiovascular Disease, published in Front Pharmacol (2026) — summary generated from the PubMed abstract.
- 2026
Front Pharmacol1 citations - Level BClinical TrialEurope PMC
Therapeutic potential of mesenchymal stem cells in ocular degenerative disorders
Clinical Trial on Immune Modulation, published in J Transl Med (2026) — summary generated from the PubMed abstract.
- 2026
J Transl Med - Level AMeta-analysisEurope PMC
Therapeutic potential of mesenchymal stromal cells in COVID-19: a meta-analysis of clinical trials conducted since the pandemic onset
Meta-analysis with a reported sample of 1080 on Chronic Inflammation, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
- n = 1080
Stem Cell Res Ther - Level AMeta-analysisPubMed
The Potential Role of Mesenchymal Stem Cell Therapy for Moderate-to-Severe Atopic Dermatitis: A Systematic Review and Meta-Analysis of Human Clinical Trials.
Meta-analysis with a reported sample of 236, published in Stem Cells Dev (2026) — summary generated from the PubMed abstract.
- 2026
- n = 236
Stem Cells Dev - Level BClinical TrialPubMed
Combination of rapamycin and adipose-derived mesenchymal stromal cells enhances therapeutic potential for osteoarthritis.
Clinical Trial on Osteoarthritis, Chronic Inflammation, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther7 citations - Level DNarrative ReviewPubMed
The Differentiation and Regeneration Potential of ABCB5 + Mesenchymal Stem Cells: A Review and Clinical Perspectives.
Narrative Review on Immune Modulation, published in J Clin Med (2025) — summary generated from the PubMed abstract.
- 2025
J Clin Med - Level BClinical TrialPubMed
Human mesenchymal stem cell therapy: Potential advances for reducing cystic fibrosis infection and organ inflammation.
Clinical Trial on Chronic Inflammation, published in Best Pract Res Clin Haematol (2025) — summary generated from the PubMed abstract.
- 2025
Best Pract Res Clin Haematol - Level CProspective StudyPubMed
Evaluation of the Safety and Regenerative Potential of Human Mesenchymal Stem Cells and Their Extracellular Vesicles in a Transgenic Pig Model of Cartilage-Bone Injury In Vivo - Preclinical Study.
Prospective Study on Osteoarthritis, Cartilage Damage, published in Stem Cell Rev Rep (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Rev Rep5 citations - Level BClinical TrialPubMed
Therapeutic Potential of Adipose Mesenchymal Stem Cells for Synovial Regeneration: from In-Vitro Studies to Clinical Applications.
Clinical Trial on Immune Modulation, published in Stem Cell Rev Rep (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Rev Rep - Level AMeta-analysisEurope PMC
Therapeutic potential of mesenchymal stem cell-derived extracellular vesicle in nonalcoholic fatty liver disease: a systematic review and meta-analysis of preclinical evidence
Meta-analysis, published in Lipids Health Dis (2025) — summary generated from the PubMed abstract.
- 2025
Lipids Health Dis3 citations - Level ASystematic ReviewEurope PMC
The therapeutic potential of mesenchymal stem cells in intestinal diseases: from mechanisms to clinical translation
Systematic Review on Chronic Inflammation, Immune Modulation, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther1 citations - Level BClinical TrialEurope PMC
Current Perspectives on Mesenchymal Stem Cells as a Potential Treatment for Periodontal Diseases and Conditions
Clinical Trial on Ligament Injury, Chronic Inflammation, Immune Modulation, published in Genesis (2025) — summary generated from the PubMed abstract.
- 2025
Genesis2 citations - Level ASystematic ReviewEurope PMC
A systematic review of preclinical studies on therapeutic potential of mesenchymal stem/stromal cells and their secretome in bacterial infections
Systematic Review, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther3 citations - Level DNarrative ReviewEurope PMC
Therapeutic potential of human umbilical cord mesenchymal stem cell-derived exosomes in myocardial infarction: from molecular mechanisms to clinical translation-an update
Narrative Review on Cardiovascular Disease, Immune Modulation, published in Front Pharmacol (2025) — summary generated from the PubMed abstract.
- 2025
Front Pharmacol - Level BClinical TrialPubMed
Enhancing the clinical potential: Quality assessment of adipose tissue-derived Mesenchymal Stem/Stromal Cells for therapeutic use.
Clinical Trial on Neuroinflammation, published in Adv Med Sci (2025) — summary generated from the PubMed abstract.
- 2025
Adv Med Sci - Level BClinical TrialEurope PMC
Mesenchymal Stromal Cells Derived from Dental Tissues: Immunomodulatory Properties and Clinical Potential
Clinical Trial on Immune Modulation, Autoimmune Research, published in Int J Mol Sci (2024) — summary generated from the PubMed abstract.
- 2024
Int J Mol Sci13 citations - Level DLaboratory StudyPubMed
Proteomic analysis and functional validation reveal distinct therapeutic capabilities related to priming of mesenchymal stromal/stem cells with IFN-γ and hypoxia: potential implications for their clinical use.
Laboratory Study, published in Front Cell Dev Biol (2024) — summary generated from the PubMed abstract.
- 2024
Front Cell Dev Biol - Level BClinical TrialEurope PMC
Therapeutic Potential and Mechanisms of Mesenchymal Stem Cell and Mesenchymal Stem Cell-Derived Extracellular Vesicles in Atopic Dermatitis
Clinical Trial on Chronic Inflammation, Immune Modulation, published in J Inflamm Res (2024) — summary generated from the PubMed abstract.
- 2024
J Inflamm Res6 citations - Level BClinical TrialPubMed
Evaluating the therapeutic potential of different sources of mesenchymal stem cells in acute respiratory distress syndrome.
Clinical Trial on Chronic Inflammation, Immune Modulation, published in Stem Cell Res Ther (2024) — summary generated from the PubMed abstract.
- 2024
Stem Cell Res Ther - Level BClinical TrialPubMed
Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles: A focus on inflammatory bowel disease.
Clinical Trial on Chronic Inflammation, Immune Modulation, Autoimmune Research, published in Clin Transl Med (2024) — summary generated from the PubMed abstract.
- 2024
Clin Transl Med - Level BClinical TrialEurope PMC
Therapeutic potential and impact of nanoengineered patient-derived mesenchymal stem cells in a murine resection and recurrence model of human glioblastoma
Clinical Trial, published in Bioeng Transl Med (2024) — summary generated from the PubMed abstract.
- 2024
Bioeng Transl Med2 citations - Level BClinical TrialEurope PMC
The Potential of Mesenchymal Stem Cells in Treating Spinocerebellar Ataxia: Advances and Future Directions
Clinical Trial on Immune Modulation, published in Biomedicines (2024) — summary generated from the PubMed abstract.
- 2024
Biomedicines10 citations - Level BClinical TrialEurope PMC
Immortalization of Mesenchymal Stem Cells for Application in Regenerative Medicine and Their Potential Risks of Tumorigenesis
Clinical Trial on Scar, Immune Modulation, published in Int J Mol Sci (2024) — summary generated from the PubMed abstract.
- 2024
Int J Mol Sci18 citations - Level DNarrative ReviewEurope PMC
Mechanisms and clinical application potential of mesenchymal stem cells-derived extracellular vesicles in periodontal regeneration
Narrative Review on Ligament Injury, published in Stem Cell Res Ther (2023) — summary generated from the PubMed abstract.
- 2023
Stem Cell Res Ther35 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406